Considerations for use of COVID-19 vaccine boosters discussed
Sep 15, 2021
Vaccine efficacy is substantially higher against severe disease than against infection; no evidence was seen for declining protection against severe disease.
Microbiome therapeutic beats placebo for recurrent C. difficile
Jan 24, 2022
In analyses stratified according to age stratum, SER-109 led to less frequent recurrence than placebo (relative risks, 0.24 and 0.36 for those younger than 65 years of age and 65 years and older, respectively)
Amid COVID-19 test shortages, price gouging Is on the rise
Jan 10, 2022
Attorney general offices around the country have reported receiving complaints or hearing stories of price gouging.
High-dose IV iron reduces myocardial infarction in patients on hemodialysis
Dec 22, 2021
High-dose versus low-dose intravenous iron reduces myocardial infarctions in patients receiving maintenance hemodialysis.
Molnupiravir cuts risk for severe COVID-19 illness in adults
Dec 20, 2021
The risk for hospitalization or death was lower in at-risk adults with mild-to-moderate COVID-19 receiving oral therapy with molnupiravir versus placebo.
USPSTF: Evidence lacking for glaucoma screening in adults
May 24, 2022
The researchers found that screening of frail elderly persons was associated with significantly greater fall risk, however.
Online breathing program can up mental health-related quality of life in long COVID
May 03, 2022
Significant improvement was seen in the mental health composite score but not in physical composite score of health-related quality of life.
CDC expert panel to weigh in on vaccine boosters
Sep 22, 2021
The panel will deliberate which high-risk groups should get a booster shot.
Heart attack, stroke care rebound during pandemic
Jun 11, 2021
The biggest, latest COVID-19 surge did not show declines in stroke, heart attack presentation as seen early in the pandemic.
FDA approves first biosimilar insulin product
Jul 29, 2021
Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine) and provides a cost-effective option.